Currency in USD
| Earnings estimate | Current qtr. (Nov 2021) | Next qtr. (Feb 2022) | Current year (2021) | Next year (2022) |
|---|
| No. of analysts | 0 | 0 | 0 | 0 |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low estimate | 0 | 0 | 0 | 0 |
| High estimate | 0 | 0 | 0 | 0 |
| Year ago EPS | -0.15 | -0.11 | N/A | N/A |
| Revenue estimate | Current qtr. (Nov 2021) | Next qtr. (Feb 2022) | Current year (2021) | Next year (2022) |
|---|
| No. of analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 105k | 75k | 196k | 284k |
| Low estimate | 1M | 3M | 1.55M | 36M |
| High estimate | 1M | 3M | 1.55M | 36M |
| Year ago sales | N/A | N/A | 30k | 196k |
| Sales growth (year/est) | N/A | N/A | 553.30% | 44.90% |
| Earnings history | 29/11/2020 | 27/02/2021 | 30/05/2021 | 30/08/2021 |
|---|
| Est. EPS | -0.08 | -0.14 | -0.12 | -0.12 |
| Actual EPS | -0.15 | -0.11 | -0.08 | -0.07 |
| Difference | -0.07 | 0.03 | 0.04 | 0.05 |
| Surprise % | -87.50% | 21.40% | 33.30% | 41.70% |
| EPS trend | Current qtr. (Nov 2021) | Next qtr. (Feb 2022) | Current year (2021) | Next year (2022) |
|---|
| Current estimate | 0 | 0 | 0 | 0 |
| 7 days ago | -0.11 | -0.09 | -0.4 | -0.18 |
| 30 days ago | -0.11 | -0.09 | -0.4 | -0.18 |
| 60 days ago | -0.11 | -0.09 | -0.4 | -0.18 |
| 90 days ago | -0.11 | -0.09 | -0.4 | -0.18 |
| EPS revisions | Current qtr. (Nov 2021) | Next qtr. (Feb 2022) | Current year (2021) | Next year (2022) |
|---|
| Up last 7 days | N/A | N/A | N/A | N/A |
| Up last 30 days | N/A | N/A | N/A | N/A |
| Down last 7 days | N/A | N/A | N/A | N/A |
| Down last 30 days | N/A | N/A | N/A | N/A |
| Growth estimates | QBIO | Industry | Sector(s) | S&P 500 |
|---|
| Current qtr. | N/A | N/A | N/A | N/A |
| Next qtr. | N/A | N/A | N/A | N/A |
| Current year | N/A | N/A | N/A | N/A |
| Next year | N/A | N/A | N/A | N/A |
| Next 5 years (per annum) | N/A | N/A | N/A | N/A |
| Past 5 years (per annum) | N/A | N/A | N/A | N/A |
